Investors Investors

Stock Quote

NASDAQ: PGNX
$5.81
0.00
4:00 PM ET on July 28

Press Releases

All Releases
View Summary Progenics Receives $50 Million Milestone Payment Following FDA Approval of RELISTOR® Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-cancer Pain
Jul 26, 2016
PDF 60.3 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Sets Second Quarter 2016 Financial Results Call for August 4
Jul 22, 2016
PDF 10.4 KB Add to Briefcase
View Summary Valeant and Progenics Announce FDA Approves RELISTOR® Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-cancer Pain
Jul 19, 2016
PDF 81.2 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
Jul 8, 2016
PDF 10.4 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Announces Presentations on its Prostate Cancer Imaging Programs at SNMMI 2016
Jun 13, 2016
PDF 12.4 KB Add to Briefcase
View Summary Bradley Campbell, President and COO of Amicus Therapeutics, elected to Progenics Board of Directors
Jun 9, 2016
PDF 11.2 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference
Jun 2, 2016
PDF 10.4 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Announces First Quarter 2016 Financial and Business Results
May 5, 2016
PDF 79.8 KB Add to Briefcase
View Summary Progenics Licenses PSMA Antibody Technology to Bayer for Development of Alpha-Radiolabeled Therapeutic Antibodies
May 2, 2016
PDF 7.7 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Sets First Quarter 2016 Financial Results Call for May 5
Apr 21, 2016
PDF 10.5 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference
Apr 6, 2016
PDF 9.8 KB Add to Briefcase
View Summary Valeant and Progenics Announce PDUFA Date Extension for Oral RELISTOR
Apr 4, 2016
PDF 75.1 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2015 Financial and Business Results
Mar 11, 2016
PDF 81.2 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Present at 28th Annual ROTH Conference
Mar 9, 2016
PDF 9.7 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Sets Fourth Quarter and Full-Year 2015 Financial Results Call for March 11
Mar 1, 2016
PDF 10.1 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Present at Upcoming Investor Conferences
Feb 1, 2016
PDF 11.8 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Commences Pivotal Phase 3 Study of PSMA Targeted Imaging Agent 1404 for Prostate Cancer
Jan 7, 2016
PDF 11.6 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Achieves Target Enrollment in its Phase 2b Pivotal Trial of Azedra™
Dec 3, 2015
PDF 10.7 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Announces the Appointment of Patrick Fabbio as Chief Financial Officer
Nov 16, 2015
PDF 13.9 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Present at the Stifel Healthcare Conference
Nov 10, 2015
PDF 9.1 KB Add to Briefcase
Showing 1-20 of 263 Page: 1 2 3 4 5 ... 14  Next 20
Add to Briefcase = add release to Briefcase